in page functions

10 December 2010

Bolivia rotavirus success

Bolivia's successful rotavirus vaccine initiative

Just one and half years after Bolivia became the first GAVI-eligible country to introduce the rotavirus vaccine, a disease responsible for almost half of all hospitalisations for diarrhoea from 2006-2008, is on the retreat.

01 December 2010

China HepB story child

China's dramatic fall in hepatitis B infections

From 2002-2010, GAVI co-funded immunisation against hepatitis B in the west and central provinces of China. Today, less than 1% of children under 5 are chronic carriers of hepB.

26 November 2010

HSS Vietnam health workers

GAVI funds training for health volunteers in Vietnam

GAVI support for strengthening the Vietnamese health service brings training and resources to even the remotest areas.

26 November 2010

EB 2011 Fig 15 Increasing global immun

GAVI helps DTP3 coverage rise after stagnation

While GAVI was set up first and foremost to help countries introduce new and under-used vaccines, its programme support has also increased global access to the long-existing vaccine against diphtheria, tetanus and pertussis (DTP).

26 November 2010

EB 2011 Fig 16 manufacturers

GAVI model increases vaccine manufacturers

The steady rise in the number of vaccine manufacturers based in emerging economies since 2001 represents a tell-tale sign of GAVI's true impact on the vaccine market.

20 November 2010

Nepal HSS health workers

Donors unite to finance Nepal health system

GAVI and other leading donors to Nepal channel their financial support through a single system to streamline assistance for the national health programme.

17 November 2010

HSS Cambodia mother child landscape

HSS raises Cambodian mothers’ survival chances

In the first five years of the millennium, Cambodia achieved an almost 30% drop in infant and child mortality rates, but improvements in women's health failed to keep pace.

01 November 2010

Vaccines boost economic growth in poorest countries

Vaccines bring added value to the economies of the world's poorest countries with GAVI's investment in immunisation set to yield an 18% rate of return by 2020, according to a Harvard School of Public Health study.

27 September 2010

Rwanda health clinic 2010 - injection

Rwanda's pneumococcal vaccine roll-out, one year on

It has been a little over a year since Rwanda introduced a pneumococcal conjugate vaccine known as PCV7. The vaccine protects children against one of the most common causes of pneumonia – with encouraging results.

09 August 2010

Table 4 GAVI donor rankings

GAVI ranks fifth in aid quality report

GAVI ranks fifth out of 38 bilateral and multilateral donors in a study measuring donors' performance against best practices established at the 2005 Paris Declaration on Aid Effectiveness.

21 July 2010

Tiered pricing

GAVI approach creates tiered pricing for vaccines

For the pharmaceutical industry to offer fixed lower prices for developing countries, manufacturers need to see a vaccine market with sufficient size and income to cover their costs.

16 June 2010

Progress report child waving

GAVI Progress Report heralds 10th anniversary

Despite the backdrop of a global financial crisis, GAVI received a record number of applications for funding from low-income countries in 2009, according to the latest edition of the Alliance's annual Progress Report.

05 May 2010

EB 2011 Fig 17 Hep B price

GAVI impact on vaccine market behind price drop

By pooling donor contributions to make long-term vaccine orders and grouping developing countries into a single large-scale buyer, GAVI is helping make life-saving new vaccines more affordable for the world's poorest.

14 April 2010

EB 2011 Fig 11 Hib vaccine

Hib Initiative: a GAVI success story

The GAVI-funded Hib Initiative paved the way for low-income countries to introduce vaccines against Haemophilus influenzae type b infection



close icon

modal window here